Today: 9 June 2026
AAOI stock slides nearly 11% after $41 pop; what Applied Optoelectronics investors watch next
5 January 2026
1 min read

AAOI stock slides nearly 11% after $41 pop; what Applied Optoelectronics investors watch next

New York, Jan 5, 2026, 13:30 EST — Regular session

  • Applied Optoelectronics shares reversed sharply after an early push above $41.
  • The optical transceiver maker remains a volatile AI data-center optics play with heavy short positioning.
  • Investors’ next focus is late-February earnings timing and execution on 800G shipments.

Applied Optoelectronics, Inc. (AAOI) shares fell nearly 11% on Monday, erasing an early jump that briefly lifted the stock above $41.

The retreat came even as broader U.S. equities and chip-related names traded higher, underlining how quickly positioning can flip in the optical components maker. Applied Optoelectronics sells optical transceivers — plug-in hardware that converts electrical signals into light to move data through fiber.

Why it matters now: the stock has become a high-beta proxy for capital spending on AI-linked data centers, where demand is shifting toward faster links. Investors are watching for clearer proof that new orders for “800G” products — 800-gigabit-per-second transceivers — are landing and shipping at scale.

Shares were down $4.25, or 10.7%, at $35.35 by 1:30 p.m. EST, after trading between $41.28 and $35.35. About 4.5 million shares had changed hands, roughly in line with the stock’s average daily volume, while the Invesco QQQ ETF was up about 0.8% and the VanEck Semiconductor ETF rose about 1.3%.

In its most recent quarterly update in November, the Sugar Land, Texas-based company reported third-quarter revenue of $118.6 million and forecast fourth-quarter revenue of $125 million to $140 million. It said it expected to exit 2025 with production capacity of around 100,000 units of 800G transceivers per month, with about 35% of that production in the United States.

In December, Applied Optoelectronics said it received its first volume order for 800G data-center transceivers from a major “hyperscale” customer — the largest cloud operators that run massive data centers. CEO Thompson Lin said, “We are pleased to receive our first volume order for our 800G products.” Stock Titan

The company said it remained on track to meet its year-end 800G shipment expectations and that those shipments could contribute $4 million to $8 million to fourth-quarter revenue.

A November SEC filing showed Applied Optoelectronics also set up a $180 million “at-the-market” equity program, which allows it to sell shares into the open market from time to time through Raymond James and Needham. Such programs can provide funding flexibility, but investors often flag dilution risk when share prices swing.

Short positioning adds another accelerant. About 19.5% of the public float — the shares available for trading — was sold short as of Dec. 15, MarketBeat data showed, meaning investors had borrowed and sold shares betting the price would fall.

But the downside case is execution: Applied Optoelectronics has said datacenter revenue can be affected by shipment timing and customer receiving schedules, and it is still working through qualification and ramp steps for higher-speed products. Any slip in deliveries or a pause in cloud spending could pressure results just as expectations rise.

Stock Market Today

  • Wall Street Eyes Modest Gains as AI Stocks Rebound, Oil Prices Decline
    June 9, 2026, 10:03 AM EDT. Wall Street opened higher Tuesday with the S&P 500 climbing 0.6%, nearing its all-time high. The tech-heavy Nasdaq rose 0.7%, led by AI-related chipmakers like Micron Technology, which rebounded after recent sharp losses. Meanwhile, oil prices slipped, with Brent crude falling 1.6% to $92.83 a barrel amid easing geopolitical tensions. The decline in fuel costs boosted major U.S. airlines, which face soaring jet fuel expenses. Elevated oil prices continue to drive inflation and push yields higher, with the 10-year U.S. Treasury yield near 4.55%. Ahead this week, U.S. inflation data and a Federal Reserve policy meeting are in focus amid expectations of steady or higher interest rates. The mixed signals reflect ongoing uncertainty in markets amid global conflicts and inflation pressures.

Latest articles

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

9 June 2026
Regentis Biomaterials shares dipped 2 cents to $1.28 premarket after the company announced European surgeon training for its GelrinC knee implant will begin in Q3, marking a key commercial step but leaving investors waiting for revenue proof as the stock trades far below its $8 IPO price.
IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

9 June 2026
IREN surged 8.9% to $59.19 and was quoted higher premarket after a bitcoin rebound and renewed focus on its pivot to AI cloud infrastructure, but the stock remains exposed to bitcoin swings, heavy spending, and risks tied to its new 800MW South Australia data center project and major contracts with Nvidia and Microsoft.
AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

9 June 2026
AT&T shares edged up to $22.58 pre-market after reaffirming 2026 guidance and a $45B+ shareholder return plan, providing a cash-flow marker as satellite broadband competition looms; the stock remains pressured by SpaceX risks flagged by Oppenheimer, with second-quarter free cash flow seen at $4.0–$4.5B.
GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

9 June 2026
GSK will buy Nuvalent for $10.6 billion in cash, paying a 40% premium, to boost its oncology pipeline ahead of looming HIV drug patent expiries; Nuvalent shares jumped 38.9% premarket while GSK fell 1.4%, with the deal expected to add to GSK sales and profit from 2027 but dilute earnings per share 2026-2028 if it closes in Q3, and final outcome depends on FDA approvals and regulatory clearance.
NuScale Power stock jumps 16% as House sets ‘New Nuclear Era’ hearing — what’s next for SMR
Previous Story

NuScale Power stock jumps 16% as House sets ‘New Nuclear Era’ hearing — what’s next for SMR

3.5 million hit by University of Phoenix data breach as school rolls out “credit for prior learning” push
Next Story

3.5 million hit by University of Phoenix data breach as school rolls out “credit for prior learning” push

Go toTop